Design and Synthesis of 2-Methyl Tryptamine-Maleimide Hybrids as a Potential Antitubercular Agents

Loading...
Thumbnail Image
Authors
Eisenbach, Carter J.
Issue Date
2022-11-01
Type
Thesis
Language
en_US
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Over 2.8 million antibiotic-resistant infections occur every year in the United States. Of these infections, drug-resistant tuberculosis is of particular concern, especially for multi-drug resistant strains. Hybridization is a novel way to synthesize antibacterial drugs with unique mechanisms of action. 2-Methyl tryptamine and 3,4-diaryl maleimide structures were selected for hybridization based on previous research demonstrating their biological activity against tuberculosis. In this study, an optimized route was found to effectively synthesize pure 2-methyl tryptamine by modifying procedures from published literature. The reaction time and rate of addition of 5-chloro-2-pentanone were manipulated to produce a pure 2-methyl tryptamine to be used for hybridization. 3,4-diaryl maleimide structures were synthesized based on previous research in the lab. With the synthesis of each component, 8 maleimide-2-methyl tryptamine hybrids were successfully synthesized (52-122% yield) and 4 were purified (21-47% yield).
Description
viii, 19 p.
Citation
Publisher
Kalamazoo College
License
U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder. All rights reserved.
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN